Discovery through Machine Learning and Preclinical Validation of Novel Anti-Diabetic Peptides

While there have been significant advances in drug discovery for diabetes mellitus over the past couple of decades, there is an opportunity and need for improved therapies. While type 2 diabetic patients better manage their illness, many of the therapeutics in this area are peptide hormones with len...

Full description

Bibliographic Details
Main Authors: Rory Casey, Alessandro Adelfio, Martin Connolly, Audrey Wall, Ian Holyer, Nora Khaldi
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/9/3/276

Similar Items